●
Policy on Release of
Prescriptions to Patient Representatives
●
Pharmacy Automation guidance letter
●
The AF/SG Patient Safety
Program Policy Memorandum
●
Department of Health and Human
Services HIPAA Privacy Rule
Summary
●
U.S. Department of Justice, Drug
Enforcement Administration Drugs
of Abuse Publication
●
HHS HIPAA Regulations and Guidance
●
AFI33-360V1 Publications
Management Program, states inChapter 3, Paragraph 3.2
that there is a finite period of
time, 120-days, that a policy or
interim guidance publication
remains in effect before it
needs to be replaced by an AFI
or other directive.
However, it also states that
AF policies and interim guidance
will REMAIN IN EFFECT
regardless of the 120-day
restriction, whether or
not they have been superseded by
AFI or directive.
